These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of echinocandin prophylaxis in solid organ transplantation. Giannella M; Husain S; Saliba F; Viale P J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i51-i59. PubMed ID: 29304212 [TBL] [Abstract][Full Text] [Related]
4. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis. Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642 [TBL] [Abstract][Full Text] [Related]
5. How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: A single-centre study. Mularoni A; Adamoli L; Polidori P; Ragonese B; Gioè SM; Pietrosi A; Tuzzolino F; Guadagnino G; Monaco F; Grossi PA; Conaldi PG; Luca A; Mikulska M Mycoses; 2020 Jul; 63(7):746-754. PubMed ID: 32358860 [TBL] [Abstract][Full Text] [Related]
6. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience. Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459 [TBL] [Abstract][Full Text] [Related]
8. Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients. Farmakiotis D; Kontoyiannis DP Am J Transplant; 2015 May; 15(5):1141-7. PubMed ID: 25655091 [TBL] [Abstract][Full Text] [Related]
9. Yeast Infections in Solid Organ Transplantation. Taimur S Infect Dis Clin North Am; 2018 Sep; 32(3):651-666. PubMed ID: 30146028 [TBL] [Abstract][Full Text] [Related]
10. Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial. Flett L; Abdelatif R; Baz SA; Brady S; Corbacho B; Common K; Cowling A; Fairhurst C; Fitzmaurice E; Gandhi S; Hilton A; Hope W; Howard A; Laycock J; Lillie P; Mitchell G; Parker A; Peel M; Sheard L; Sneddon J; Taynton T; Tharmanathan P; Torgerson D; Wang HI; Allsup D; Barlow G Trials; 2024 Jun; 25(1):427. PubMed ID: 38943201 [TBL] [Abstract][Full Text] [Related]
11. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection. Anesi JA; Baddley JW Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603 [TBL] [Abstract][Full Text] [Related]
12. Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona. Al-Obaidi MM; Marquez J; Afghan A; Zangeneh TT Mycoses; 2023 Mar; 66(3):237-241. PubMed ID: 36401812 [TBL] [Abstract][Full Text] [Related]
13. Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients. Cabrera NL; George IA; Rauseo AM; Mazi P; Spec A Curr Opin Organ Transplant; 2022 Aug; 27(4):235-242. PubMed ID: 36354248 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of invasive mold infections in solid organ transplant recipients. Fernández-Ruiz M Expert Opin Pharmacother; 2024 Feb; 25(3):239-254. PubMed ID: 38436619 [TBL] [Abstract][Full Text] [Related]
15. [Invasive yeast diseases in solid organ transplant recipients]. Muñoz P; Aguado JM Rev Iberoam Micol; 2016; 33(3):152-9. PubMed ID: 27142561 [TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076 [TBL] [Abstract][Full Text] [Related]
17. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response. Neofytos D; Garcia-Vidal C; Lamoth F; Lichtenstern C; Perrella A; Vehreschild JJ BMC Infect Dis; 2021 Mar; 21(1):296. PubMed ID: 33761875 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients? Salavert M Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340 [TBL] [Abstract][Full Text] [Related]
19. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103 [TBL] [Abstract][Full Text] [Related]
20. Defining standards of CARE for invasive fungal diseases in solid organ transplant patients. Garcia-Vidal C; Carratalà J; Lortholary O J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii16-ii20. PubMed ID: 31222312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]